Literature DB >> 11111917

Crystal structure of the F component of the Panton-Valentine leucocidin.

J D Pédelacq1, G Prévost, H Monteil, L Mourey, J P Samama.   

Abstract

Leucocidins and gamma-hemolysins are bi-component staphylococcal toxins that form lytic transmembrane pores. Their cytotoxic activities involve the synergistic association of a class S and a class F component, produced as water-soluble monomers which assemble on the surface of specific cells. The structure of the F protein from Panton-Valentine leucocidin, solved at 2.0 A resolution, and sequence alignment suggest that it represents the fold of any secreted protein in this family of toxins. The comparison of this structure to that of the homoheptameric alpha-hemolysin provides some insights into the molecular events that may occur during pore formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11111917     DOI: 10.1016/S1438-4221(00)80050-8

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  4 in total

1.  Arresting and releasing Staphylococcal alpha-hemolysin at intermediate stages of pore formation by engineered disulfide bonds.

Authors:  Toshimitsu Kawate; Eric Gouaux
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

2.  Vertical collapse of a cytolysin prepore moves its transmembrane beta-hairpins to the membrane.

Authors:  Daniel M Czajkowsky; Eileen M Hotze; Zhifeng Shao; Rodney K Tweten
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

Review 3.  Targeting and inactivation of bacterial toxins by human defensins.

Authors:  Elena Kudryashova; Stephanie M Seveau; Dmitri S Kudryashov
Journal:  Biol Chem       Date:  2017-09-26       Impact factor: 4.700

4.  Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.

Authors:  Hatice Karauzum; Rajan P Adhikari; Jawad Sarwar; V Sathya Devi; Laura Abaandou; Christian Haudenschild; Mahta Mahmoudieh; Atefeh R Boroun; Hong Vu; Tam Nguyen; Kelly L Warfield; Sergey Shulenin; M Javad Aman
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.